Get Quote
 
 
Gainers Losers Latest NAV Scheme Profile  
 
Search Scheme 

SCHEME SNAPSHOT

Reliance Japan Equity Fund
Fund : Reliance Mutual Fund
Category : Equity - Diversified
Type : Open Ended
NAV(23/06/2017) 11.2022
Percentage Returns :
1 Month Ago : 1.18%
3 Months Ago : 5.24%
1 Year Ago : 10.79%
Snapshot
Inception Date 8/8/2014 Fund Manager Ms. Jahnvee Shah
Initial Price 10.00 Min. Invest. Rs.5000
Objectives The primary investment objective of Reliance Japan Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on the recognized stock exchanges of Japan and the secondary objective is to generate consistent returns by investing in debt and money market securities of India.
Entry Load Nil
Exit Load
Trailing Returns
  1 Mth 3 Mths 1 Yr 3 Yrs
Scheme1.185.2410.790
Category2.546.8622.3639.47
Sensex2.556.1615.327.55
Nifty2.015.3815.778.51
NAV Chart
Other Options  Asset Allocation
OptionsNAV
Bonus11.2022 (23/06/2017)
Dividend11.2022 (23/06/2017)
Growth11.2022 (23/06/2017)
Holding DateValue (Rs. Cr)
30/04/201726.67
28/02/201727.12
31/01/201727.05
31/12/201626.53
31/10/201627.23
Mutual Fund Registrar
Reliance Centre, 7th Floor South Wing, Off Western Express Highway, Santacruz (East), Mumbai, Maharashtra, India - 400055
Email : customer_care@reliancemutual.com
Web : http://www.reliancemutual.com
Karvy Computershare Pvt. Ltd.
 

Sector Watch

 
  Company
Name
NSE
Current
NSE
Change (%)
NSE
Volume
BSE
Current
BSE
Change (%)
BSE
Volume
849.75 0.93 591,602
847.60 0.68 18,544
257.30 -1.15 3,234,463
257.40 -1.21 183,433
93.40 -0.32 6,118,660
93.20 -0.53 663,663
2,845.70 1.00 223,966
2,840.45 0.69 15,569
1,154.75 -1.14 312,362
1,154.30 -1.17 30,973
24,286.40 0.25 11,720
24,277.00 -0.09 797

TOP MF News

Mutual fund managers continued to be bullish on bank shares, with their allocation to the sector reaching an all time-high of over...

Company News

Drug firm Wockhardt today said it has settled an ongoing lawsuit over supply contract for a product with Teva Pharmaceuticals. The...